Hematopathology Fellowship Program

Scholarly Activities and Research

Participation in a scholarly project is mandatory. Fellows are encouraged to identify a mentor/supervisor and a research project as early as possible.  The results of their research will be presented at the HP Educational Conference at the end of the year.  Presentation at a national meeting and/or publication in a peer-reviewed journal is the primary goal.


Scopes and types of scholarly activity

  • Primary research project: depend on the interests and prior experience of the fellow. Typical project types include morphologic reviews, immunophenotyping studies, molecular diagnostics or clinical cytogenetics-based studies, and/or any other pertinent clinical/translational research. As part of the research requirement, fellows are responsible for obtaining institutional internal review board (IRB) approval for new projects if necessary.
  • Case reports
  • Review articles (including book chapters)
  • Laboratory management projects leading to publication or presentation at a national meeting


Examples of Scholarly Activity from Prior Fellows


  1. Olson N, Shao L, Ross C, Dewar R. B-lymphoblastic leukemia/lymphoma with homozygous 9p21.3 deletion and marked eosinophila. SH/EAHP workshop on eosinophilia and mastocytosis, Phoenix, AZ, 9/2019
  2. Olson N, Dewar R. Diffuse large B-cell lymphoma, germinal center B-cell subtype. Performance Improvement Program Series in Surgical Pathology, College of American Pathologists, College of American Pathologists PIP-D 2019; Case 2019-40.
  3. NPM-ALK phosphorylates WASp Y102 and contributes to oncogenesis of anaplastic large cell lymphoma. Murga-Zamalloa CA, Mendoza-Reinoso V, Sahasrabuddhe AA, Rolland D, Hwang SR, McDonnell SR, Sciallis AP, Wilcox RA, Bashur V, Elenitoba-Johnson K, Lim MS. Oncogene. 2017 Apr;36(15):2085-2094. PMID: 27694894. 2017 Benjamin Castleman Award, United States and Canadian Academy of Pathology.
  4. T-cell Receptor Signaling Activates an ITK/NF-κB/GATA-3 axis in T-cell Lymphomas Facilitating Resistance to Chemotherapy. Wang T, Lu Y, Polk A, Chowdhury P, Murga-Zamalloa C, Fujiwara H, Suemori K, Beyersdorf N, Hristov AC, Lim MS, Bailey NG, Wilcox RA. Clin Cancer Res. 2017 May 15;23(10):2506-2515.
  5. Pyrimidine tract-binding protein 1 mediates pyruvate kinase M2-dependent phosphorylation of signal transducer and activator of transcription 3 and oncogenesis in anaplastic large cell lymphoma. Hwang SR, Murga-Zamalloa C, Brown N, Basappa J, McDonnell SR, Mendoza-Reinoso V, Basrur V, Wilcox R, Elenitoba-Johnson K, Lim MS. Lab Invest. 2017 Apr 17 (In press). PMID: 28414323.
  6. Hathuc V, Hristov A, Smith L. Primary Cutaneous Acral CD8+ T cell lymphoma. Archives of Pathology and Laboratory Medicine (Accepted for publication)
  7. Charles NJ, Boyer DF. Mixed Phenotype Acute Leukemia: Diagnostic Criteria and Pitfalls.  Arch Pathol Lab Med.  In press.



  1. Olson N, Choi S. The effects of ruxolitinib on bone marrow cellularity. United States and Canadian Academy of Pathology Annual Meeting. National Harbor, MD. 2019
  2. Eliaszadeh S, Dewar R. Checkpoint inhibition in Lymphoma therapy: Variable expression of CD38 in bone marrow versus nodal tissue of NHL patients may regulate lymphoma micro-environment and hence predict relapse and responsiveness to therapy (USCAP 2018)
  3. Role of the Colony-Stimulator Factor-1 Receptor (CSF1R) T-cell Lymphoma Progression. Carlos Murga-Zamalloa, Avery Polka, Noah Brown, Nathaniel Bailey, Ryan Wilcox. United States and Canadian Academy of Pathology (USCAP), San Antonio, USA (2017).  2017 Stowell-Orbison Award, Annual USCAP Meeting.
  4. Hathuc V, Smith L. 2016 Revision of the World Health Organization Classification of Lymphoid Neoplasms. New Frontiers in Diagnostic Pathology conference 2016, Ann Arbor, MI.
  5. Hathuc V, Walkovich K, Bixby D, Smith L. Familial Acute Myeloid Leukemia/Myelodysplastic Syndrome with Germline RUNX1 Mutations: A Single Institution Experience. United States and Canadian Academy of Pathology meeting 2017, San Antonio, TX.
  6. Hathuc V, East E, Pang J, Jorns J, Dewar R. A Practical Quality Control Procedure for Decalcified Bone Specimens in Evaluation of ER/PR/HER-2 Immunohistochemistry. United States and Canadian Academy of Pathology meeting 2017, San Antonio, TX.